Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02972060
Title ODM-201 vs Androgen Deprivation Therapy in Hormone naive Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

prostate cancer

Therapies

Triptorelin

Leuprolide

Degarelix

Goserelin

Darolutamide

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme Brussels 1070 Belgium Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
CHU Dinant Godinne - UCL Namur Yvoir 5530 Belgium Details
CHU de Dijon - Centre Georges-Francois-Leclerc Dijon 21079 France Details
Gustave Roussy Villejuif 94805 France Details
Azienda Ospedaliera Citta della Salute e della Scienza di Torino - Ospedale Molinette Torino 10126 Italy Details
Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol Badalona 08916 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
Hospital Universitario Virgen De La Victoria Malaga 29010 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Fundacion Instituto Valenciano De Oncologia Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field